BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25953835)

  • 1. Heat shock protein 70 overexpression does not attenuate atrophy in botulinum neurotoxin type A-treated skeletal muscle.
    Houston FE; Hain BA; Adams TJ; Houston KL; O'Keeffe R; Dodd SL
    J Appl Physiol (1985); 2015 Jul; 119(1):83-92. PubMed ID: 25953835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the proteasome partially attenuates atrophy in botulinum neurotoxin treated skeletal muscle.
    Houston FE; Hain BA; Dodd SL
    Toxicon; 2018 Mar; 144():48-54. PubMed ID: 29407164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsp70 overexpression inhibits NF-kappaB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy.
    Senf SM; Dodd SL; McClung JM; Judge AR
    FASEB J; 2008 Nov; 22(11):3836-45. PubMed ID: 18644837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70.
    Senf SM; Dodd SL; Judge AR
    Am J Physiol Cell Physiol; 2010 Jan; 298(1):C38-45. PubMed ID: 19864323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of IkappaB kinase alpha (IKKα) or IKKbeta (IKKβ) plus forkhead box O (Foxo) abolishes skeletal muscle atrophy.
    Reed SA; Senf SM; Cornwell EW; Kandarian SC; Judge AR
    Biochem Biophys Res Commun; 2011 Feb; 405(3):491-6. PubMed ID: 21256828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-κB but not FoxO sites in the MuRF1 promoter are required for transcriptional activation in disuse muscle atrophy.
    Wu CL; Cornwell EW; Jackman RW; Kandarian SC
    Am J Physiol Cell Physiol; 2014 Apr; 306(8):C762-7. PubMed ID: 24553183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsp27 inhibits IKKbeta-induced NF-kappaB activity and skeletal muscle atrophy.
    Dodd SL; Hain B; Senf SM; Judge AR
    FASEB J; 2009 Oct; 23(10):3415-23. PubMed ID: 19528257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted ablation of the cellular inhibitor of apoptosis 1 (cIAP1) attenuates denervation-induced skeletal muscle atrophy.
    Lala-Tabbert N; Lejmi-Mrad R; Timusk K; Fukano M; Holbrook J; St-Jean M; LaCasse EC; Korneluk RG
    Skelet Muscle; 2019 May; 9(1):13. PubMed ID: 31126323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Branched-chain amino acids reduce hindlimb suspension-induced muscle atrophy and protein levels of atrogin-1 and MuRF1 in rats.
    Maki T; Yamamoto D; Nakanishi S; Iida K; Iguchi G; Takahashi Y; Kaji H; Chihara K; Okimura Y
    Nutr Res; 2012 Sep; 32(9):676-83. PubMed ID: 23084640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.
    Baehr LM; Furlow JD; Bodine SC
    J Physiol; 2011 Oct; 589(Pt 19):4759-76. PubMed ID: 21807613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise training decreases NADPH oxidase activity and restores skeletal muscle mass in heart failure rats.
    Cunha TF; Bechara LR; Bacurau AV; Jannig PR; Voltarelli VA; Dourado PM; Vasconcelos AR; Scavone C; Ferreira JC; Brum PC
    J Appl Physiol (1985); 2017 Apr; 122(4):817-827. PubMed ID: 28104751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of skeletal muscle atrophy by a proteasome inhibitor in a rat model of denervation.
    Beehler BC; Sleph PG; Benmassaoud L; Grover GJ
    Exp Biol Med (Maywood); 2006 Mar; 231(3):335-41. PubMed ID: 16514182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of IGF-I and the TNFα/NF-κB pathway in the induction of muscle atrogenes by acute inflammation.
    Schakman O; Dehoux M; Bouchuari S; Delaere S; Lause P; Decroly N; Shoelson SE; Thissen JP
    Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E729-39. PubMed ID: 22739109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of altered ubiquitin-proteasome system and ER stress in the muscle atrophy of diabetic rats.
    Reddy SS; Shruthi K; Prabhakar YK; Sailaja G; Reddy GB
    Arch Biochem Biophys; 2018 Feb; 639():16-25. PubMed ID: 29277369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
    Reed SA; Sandesara PB; Senf SM; Judge AR
    FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IκBα degradation is necessary for skeletal muscle atrophy associated with contractile claudication.
    Hain BA; Dodd SL; Judge AR
    Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R595-604. PubMed ID: 21209383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leucine Protects Against Skeletal Muscle Atrophy in Lipopolysaccharide-Challenged Rats.
    Wan J; Chen D; Yu B; Luo Y; Mao X; Zheng P; Yu J; Luo J; He J
    J Med Food; 2017 Jan; 20(1):93-101. PubMed ID: 28009536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway.
    Yimlamai T; Dodd SL; Borst SE; Park S
    J Appl Physiol (1985); 2005 Jul; 99(1):71-80. PubMed ID: 15774696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
    Castillero E; Alamdari N; Lecker SH; Hasselgren PO
    Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular signaling pathways regulating muscle proteolysis during atrophy.
    Franch HA; Price SR
    Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):271-5. PubMed ID: 15809529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.